Birdwatch Note Rating
2024-01-27 17:03:59 UTC - HELPFUL
Rated by Participant: F7EB0F4783B77F158A8E3A0FDCA3ECE8F416F13F6FE18645C035388361AF08E4
Participant Details
Original Note:
Of a total of 64 outcomes in studies of GET, NICE graded 52 (81%) as “VERY LOW” quality and 12 (19%) as “LOW” quality. It has been established that GET is not a suitable treatment for MECFS, and a significant cohort of Long Covid patients meet MECFS diagnostic criteria. https://www.nice.org.uk/guidance/gid-ng10091/documents/evidence-review-7
All Note Details